Caricamento...
SAT-485 Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series
Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series Introduction: Thyroid dysfunction is reported in 5 - 9.5 % of patients treated with Pembrolizumab, one of the PD-1 immune checkpoint inhibitors. However, the underlying mechanism of Pembrolizumab-induced thyroid disord...
Salvato in:
| Pubblicato in: | J Endocr Soc |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7207765/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.155 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|